Prevalence and trends in antipsychotic polypharmacy among Medicaid eligible schizophrenia patients in California and Georgia, 1998-2000

被引：0
|
作者：
Ganguly, R [1 ]
Miller, LS [1 ]
Martin, BC [1 ]
机构：
[1] Univ Georgia, Athens, GA 30602 USA
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64218-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：347 / 348
页数：2
相关论文
共 36 条
  • [1] Prevalence, trends, and factors associated with antipsychotic polypharmacy among medicaid-eligible schizophrenia patients, 1998-2000
    Ganguly, R
    Kotzan, JA
    Miller, LS
    Kennedy, K
    Martin, BC
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (10) : 1377 - 1388
  • [2] Long term antipsychotic polypharmacy is common among Medicaid recipients with schizophrenia
    Ganguly, R.
    Kotzan, J. A.
    Miller, L. S.
    Martin, Dr Bradley C.
    [J]. EVIDENCE-BASED MENTAL HEALTH, 2005, 8 (02) : 55 - 55
  • [3] Association between antipsychotic treatment and hyperlipidemia among california medicaid patients with schizophrenia
    Lambert, BL
    Chang, KY
    Tafesse, E
    Carson, W
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (01) : 12 - 18
  • [4] Trends in and Predictors of Long-Term Antipsychotic Polypharmacy Use Among Ohio Medicaid Patients with Schizophrenia, 2008-2014
    Fontanella, Cynthia A.
    Hiance-Steelesmith, Danielle L.
    Guirgis, Hossam
    Campo, John V.
    [J]. PSYCHIATRIC SERVICES, 2018, 69 (09) : 1015 - 1020
  • [5] Use of antipsychotic polypharmacy among patients with schizophrenia and risk of death
    Gasse, Christiane
    Baandrup, Lone
    Nordentoft, Merete
    Glenthoj, Birte Y.
    Lublin, Henrik
    Jensen, Vibeke Dahl
    Thomsen, Lars Krogsgaard
    Poulsen, Jan
    Mortensen, Preben B.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S204 - S205
  • [6] Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: Experience in a multistate Medicaid population, 1998-2003
    Morrato, Elaine H.
    Dodd, Sheri
    Oderda, Gary
    Haxby, Dean G.
    Allen, Richard
    Valuck, Robert J.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (01) : 183 - 195
  • [7] USE OF CLOZAPINE AND ANTIPSYCHOTIC POLYPHARMACY AMONG PATIENTS WITH SCHIZOPHRENIA: CHARACTERIZING THE PRESCRIBERS
    Tang, Y.
    Horvitz-Lennon, M.
    Gellad, W. F.
    Normand, S. T.
    Donohue, J. M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A127 - A128
  • [8] Polypharmacy with antipsychotic drugs in patients with schizophrenia: Trends in multiple health care systems
    Sun, FangFang
    Stock, Eileen
    Copeland, Laurel
    Zeber, John
    Ahmedani, Brian
    Morissette, Sandra
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (09) : 728 - 738
  • [9] Current and future forecasts of service use and expenditures of Medicaid-eligible schizophrenia patients in the State of Georgia
    Miller, LS
    Martin, BC
    [J]. SCHIZOPHRENIA BULLETIN, 2004, 30 (04) : 983 - 995
  • [10] Six-year continuous service utilization and expenditures of Medicaid eligible schizophrenia patients in the State of Georgia
    Martin, BC
    Miller, LS
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 346 - 346
1234